22 Dec 2009 Genentech Submits Supplemental Application to FDA for Lucentis in Patients with Retinal Vein Occlusion
22 Dec 2009 to-BBB and Lundbeck to join forces on brain delivery of antibodies for CNS diseases
21 Dec 2009 UCB announces initial clinical trial results involving patients taking certolizumab pegol for moderate to severe Crohn's disease
21 Dec 2009 Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with GlaxoSmithKline
18 Dec 2009 Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union
18 Dec 2009 Cangene receives a positive opinion from the European Medicines Agency ("EMA") for Hepatitis B product
18 Dec 2009 Thallion Announces Letter of Intent with LFB Biotechnologies to Develop and Commercialize Shigamabs®
18 Dec 2009 Herceptin receives positive opinion in record time for the treatment of HER2-positive advanced stomach cancer in Europe
17 Dec 2009 Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two Existing Partnerships
15 Dec 2009 Celldex Therapeutics Presents Positive Results from Phase 2 Study of the Antibody-Drug Conjugate (ADC) Product Candidate CDX-011 in Advanced Breast Cancer
15 Dec 2009 Seattle Genetics and Millennium: The Takeda Oncology Company Announce Strategic Collaboration for Novel Late Stage Lymphoma Program Brentuximab Vedotin (SGN-35)
14 Dec 2009 New Phase II Study Showed Trastuzumab-DM1 Shrank Tumors in Women With Highly Advanced HER2-positive Breast Cancer
11 Dec 2009 Seattle Genetics Announces Termination of Collaboration Agreement with Genentech for Dacetuzumab (SGN-40)
11 Dec 2009 Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
11 Dec 2009 Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
11 Dec 2009 Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Woman Previously Treated with Chemotherapy for Advanced Breast Cancer
10 Dec 2009 Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
08 Dec 2009 Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
08 Dec 2009 SAR3419 Phase I Study Results in non-Hodgkin's Lymphoma at ASH
08 Dec 2009 Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting
08 Dec 2009 Novo Nordisk licenses IL-21 mAb and patent rights to IL-21 antibodies from ZymoGenetics
08 Dec 2009 Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia
08 Dec 2009 Immunomedics Reports Updated Results of Subcutaneous Humanized Anti-CD20 Antibody Therapy of Lymphoma With Veltuzumab

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up